Accuray (NSDQ:ARAY) touted landed a new exclusive contract to offer its CyberKnife M6 and TomoTherapy HDA devices to members of Premier Inc. at special rates.

The California-based radiosurgery devices maker said it hopes the deal will "significantly increase visibility" for its devices. Premier represents more than 3,000 hospitals and 110,000 other healthcare providers, Accuray said.

"We believe the Premier agreement will provide improved deal visibility to radiation equipment purchasing decisions earlier in the process and, ultimately, result in new opportunities for Accuray equipment and services," Accuray president & CEO Joshua Levine said in prepared remarks. "The partnership also validates our focus on service excellence and technology performance, and demonstrates the confidence the radiation oncology community has in the unique benefits of the CyberKnife and TomoTherapy Systems."

The contract took effect Sept. 1, 2014 and covers a 3-year period, according to the company statement.

The deal is more good new for Accuray, which has been making progress in recent months. The company closed the books on a long-standing patent infringement and poaching lawsuit earlier this month and boosted its full-year outlook in May after posting strong results for its 3rd quarter.